[1]DANAN G,TESCHKE R.RUCAM in drug and herb induced liver injury:the update[J].Int J Mol Sci,2016,17(1):14-46.
|
[2]DANAN G,BENICHOU C.Causality assessment of adverse reactions to drugs——I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-1330.
|
[3]AITHAL GP,WATKINS PB,ANDRADE RJ,et al.Case definition and phenotype standardization in drug-induced liver injury[J].Clin Pharmacol Ther,2011,89(6):806-815.
|
[4]ROCKEY DC,SEEFF LB,ROCHON J,et al.Causality assessment in drug-induced liver injury using a structured expert opinion process:comparison to the roussel-uclaf causality assessment method[J].Hepatology,2010,51(6):2117-2126.
|
[5]BEGAUD B,EVREUX JC,JOUGLARD J,et al.Unexpected or toxic drug reaction assessment(imputation).Actualization of the method used in France[J].Therapie,1985,40(2):111-118.
|
[6]DANAN G.Causality assessment of drug-induced liver injury.Hepatology Working Group[J].J Hepatol,1988,7(1):132-136.
|
[7]BENICHOU C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11(2):272-276.
|
[8]HAYASHI PH.Causality assessment in drug-induced liver injury[J].Semin Liver Dis,2009,29(4):348-356.
|
[9]CHALASANI NP,HAYASHI PH,BONKOVSKY HL,et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol,2014,109(7):950-966.
|
[10]Drug-induced Liver Disease Study Group,Chinese.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|